In Vivo Efficacy of Continuous Infusion versus Intermittent Dosing of Linezolid Compared to Vancomycin in a Methicillin-Resistant Staphylococcus aureus Rabbit Endocarditis Model

Linezolid is the first drug issued from the oxazolidinones, a novel class of antimicrobial agents with potent activity against gram-positive pathogens. A rabbit endocarditis model was used to compare the in vivo activities of different linezolid regimens mimicking intermittent dosing of 10 mg/kg of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jacqueline, Cédric, Batard, Eric, Perez, Lucia, Boutoille, David, Hamel, Antoine, Caillon, Jocelyne, Kergueris, Marie-France, Potel, Gilles, Bugnon, Denis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2002
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC132754/
https://ncbi.nlm.nih.gov/pubmed/12435665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.12.3706-3711.2002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak